Provided by Tiger Trade Technology Pte. Ltd.

BioRestorative Therapies, Inc.

0.1495
-0.0522-25.88%
Volume:3.30M
Turnover:520.57K
Market Cap:3.81M
PE:-0.14
High:0.1788
Open:0.1640
Low:0.1425
Close:0.2017
52wk High:1.73
52wk Low:0.1425
Shares:25.48M
Float Shares:23.76M
Volume Ratio:11.43
T/O Rate:13.90%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0878
EPS(LYR):-1.5837
ROE:-241.14%
ROA:-118.81%
PB:1.26
PE(LYR):-0.09

Loading ...

Nov 08, 2021

Major Issues Report

8-K - Current report
Nov 04, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Nov 04, 2021

Correspondence

CORRESP [Cover] - Correspondence
Nov 04, 2021

Correspondence

CORRESP [Cover] - Correspondence
Oct 29, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Oct 26, 2021

Major Issues Report

8-K - Current report
Oct 20, 2021

Major Issues Report

8-K - Current report
Oct 18, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Aug 17, 2021

Major Issues Report

8-K - Current report
Aug 16, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
May 17, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 30, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Apr 30, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Apr 12, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 12, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 05, 2021

Major Issues Report

8-K/A [Amend] - Current report
Mar 29, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 19, 2021

Major Issues Report

8-K - Current report
Mar 19, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership